State Of Wyoming Astrazeneca PLC Transaction History

State Of Wyoming

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $4,385 - $5,264	-74 Reduced 98.67%	1 $0
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $23,848 - $28,727	-428 Reduced 85.09%	75 $5,000
Q4 2021 Feb 11, 2022	BUY	$54.02 - $63.83 $27,118 - $32,042	502 Added 50200.0%	503 $29,000
Q3 2021 Feb 11, 2022	BUY	$55.56 - $60.79 $55 - $60	1 New	1 $0

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.